MGI Pharma

MGI PHARMA, Inc. is a pharmaceutical company that acquires, develops and markets differentiated, specialty pharmaceutical products. The company's primary business activities are: * identifying and acquiring products for development

and marketing,

* conducting drug development programs, and

* marketing pharmaceutical products in the United

States and establishing marketing relationships

abroad.

MGI's current product portfolio is comprised of products that address special needs in the fields of cancer and rheumatology.

Contact Details: 5775 West Old Shakopee Road Suite 100 Bloomington MN 55437 United States of America Tel: (952) 346-4700 or 800-562-0679 Fax: (952) 346-4800 Email: ir@mgipharma.com WWW: www.mgipharma.com/

Loading...

Recent Publications by MGI Pharma:
Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor. BACKGROUND: Palonosetron is a 5-HT(3)-receptor antagonist (5-HT(3)-RA)...	18th July, 2008	Research and Translational Development, MGI PHARMA INC, 6611 Tributary	Anesth Analg. 2008 Aug;107(2):469-78. DOI Direct Link
Synthesis and biological evaluation of D-amino acid oxidase inhibitors. D-amino acid oxidase (DAAO) catalyzes the oxidation of D-amino acids...	30th May, 2008	MGI Pharma, Inc.	J Med Chem. 2008 Jun 26;51(12):3357-9. Epub 2008 May 29. DOI Direct Link
Progress in the discovery and development of glutamate carboxypeptidase II inhibitors. During the past 10 years, substantial progress has been made in the...	5th March, 2008	MGI Pharma, Inc., 6611 Tributary Street, Baltimore, MD 21224, USA.	Drug Discov Today. 2007 Sep;12(17-18):767-76. Epub 2007 Aug 27. DOI Direct Link
Creating real benefit for patients at risk of nausea and vomiting: palonosetron-from bench to bedside. A Review of a Satellite Symposium Held in Conjunction With the 14th...	20th February, 2008	MGI PHARMA, Baltimore, MD, USA.	Clin Adv Hematol Oncol. 2007 Dec;5(12 Suppl 19):1-20.
Palonosetron: a unique 5-HT3 receptor antagonist indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting. Despite the advance in supportive care that occurred with the introduction...	15th September, 2007	MGI Pharma, Inc., Bloomington,	Clin Adv Hematol Oncol. 2004 May;2(5):284-9.
→View more MGI Pharma research publications.

BioNews Results for MGI Pharma:
Cancer Services provides help in hard times	Los Alamos Monitor:  Aug 17 2008 1:01AM Matching: mgi pharma
Milestone Biosciences, LLC Further Strengthens Executive Management Team	Healthcare Sales & Marketing Network:  Aug 15 2008 1:03PM Matching: mgi pharma
Milestone Biosciences, LLC Further Strengthens Executive Management Team	KOTA Territory News:  Aug 15 2008 8:29AM Matching: mgi pharma
Znomics Appoints Mark. A. Philip, Ph.D., as New President and Chief Executive Officer	NewsBlaze:  Aug 15 2008 3:29PM Matching: mgi pharma
Milestone Biosciences, LLC Further Strengthens Executive Management Team	TickerTech.com:  Aug 14 2008 9:24PM Matching: mgi pharma
Promote your company here: BioNewsCast - Press Release Distribution	→View more MGI Pharma news.

MGI Pharma Patents:
US Patent No.	Title
7241742	CYP1B1 nucleic acids and methods of use
5331107	Herbicide resistance in plants
5718079	Herbicide resistance in plants
5723632	Total synthesis of antitumor acylfulvenes
6211438	Herbicide resistance in plants
→View more MGI Pharma patents.

MGI Pharma (MOGN) Financial information Links from Barchart
MOGN Quote from from Barchart.com
MOGN Chart from from Barchart.com
MOGN Profile from from Barchart.com
MOGN Opinion from from Barchart.com
→View more MGI Pharma finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 191 times since April 2007, the link to the organisation's website has been followed 42 times

Recent Search Terms used to find this page: mgi pharma | MGI Pharma dipeptidyl peptidase IV inhibitors | .

Search for more companies in Bloomington

Search for more companies in MN

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for MGI Pharma